Mateon Therapeutics

Company Listings from SPi: Mateon Therapeutics

You are here: Home >> SPi Company Listings >> Mateon Therapeutics

 

Mateon Therapeutics

Website:
http://

Search for other references to "mateon" on SPi News

Latest Mateon Therapeutics News

Mateon Therapeutics to Present at the Rodman & Renshaw Investor Conference on September 6, 2018 SOUTH SAN FRANCISCO, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), a biopharmaceutical company developing drugs for the treatment of orphan on...... 14:00 GMT Thursday 30th August 2018

Mateon Therapeutics Receives Notice of Partial Clinical Hold for OX1222 Study SOUTH SAN FRANCISCO, Calif., Aug. 17, 2018 (GLOBE NEWSWIRE) -- (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology in...... 13:50 GMT Friday 17th August 2018

Mateon Therapeutics Reports Second Quarter 2018 Financial Results SOUTH SAN FRANCISCO, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology in...... 21:25 GMT Tuesday 14th August 2018

Mateon Therapeutics Reports First Quarter 2018 Financial Results SOUTH SAN FRANCISCO, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology ind...... 12:45 GMT Monday 14th May 2018

Mateon Therapeutics Provides Business Update and Reports 2017 Financial Results SOUTH SAN FRANCISCO, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology i...... 21:35 GMT Monday 16th April 2018

Mateon Therapeutics Raises Net Proceeds of Approximately $2.4 Million in Financing Transaction SOUTH SAN FRANCISCO, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- . (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology...... 21:10 GMT Monday 16th April 2018

Mateon Announces New Preclinical Data Demonstrating Enhanced Tumor Immune Responses when CA4P is Given in Combination with Checkpoint Inhibitors SOUTH SAN FRANCISCO, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- . (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology i...... 12:15 GMT Monday 8th January 2018

Mateon Therapeutics to Present at the 2018 Biotech Showcase SOUTH SAN FRANCISCO, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatm...... 12:30 GMT Wednesday 3rd January 2018

Mateon Provides Corporate Update and Reports Third Quarter 2017 Financial Results SOUTH SAN FRANCISCO, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatm...... 13:00 GMT Tuesday 14th November 2017

Mateon Therapeutics Announces Updated Data from Fifth Cohort of Phase 1b Study of OXi4503 in Acute Myeloid Leukemia SOUTH SAN FRANCISCO, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- . (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology i...... 12:45 GMT Monday 30th October 2017

Buy Mateon Therapeutics
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us